Wegovy is a weekly injectable prescription drug used along with lifestyle changes, including a reduced-calorie meal plan and increased physical activity, for chronic weight management
Its unique mechanism targets GLP-1 alongside glucagon receptor pathways, and studies examine its metabolic effects on energy expenditure, energy balance, glucose regulation, and gastric emptying
When it comes to medical weight loss, two of the biggest names in the conversation are semaglutide and Mounjaro
of weight loss for a 180-lb
Standard Dosing Protocols and Escalation Schedules Semaglutide treatment typically begins at a low dose and escalates weekly or every few weeks to minimize gastrointestinal side effects and allow metabolic adaptation
Yes, laxatives can generally be used safely alongside GLP-1 medications like semaglutide and tirzepatide, but timing, type, and dosage require provider guidance